Anxiety Disorders: David R. Rosenberg and Jennifer A. Chiriboga
Anxiety Disorders: David R. Rosenberg and Jennifer A. Chiriboga
Anxiety Disorders: David R. Rosenberg and Jennifer A. Chiriboga
School anxiety,
Separation performance anxiety
Normative fears
Downloaded for Anonymous User (n/a) at GEORGE WASHINGTON UNIVERSITY from ClinicalKey.com by Elsevier on July
22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
210.e2 Part III ◆ Behavioral and Psychiatric Disorders
Keywords
separation anxiety disorder
childhood-onset social phobia
social anxiety disorder
social effectiveness therapy for children (SET-C)
school refusal
selective mutism
panic disorder
generalized anxiety disorders
OCD
PTSD
CBT
SSRI safety
SSRI efficacy
Downloaded for Anonymous User (n/a) at GEORGE WASHINGTON UNIVERSITY from ClinicalKey.com by Elsevier on July
22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
Chapter 38 ◆ Anxiety Disorders 211
Preoccupation with orderliness and routines (just right phenomena) harm befalling the affected child or the child’s primary caregivers,
often takes on a quality of anxiety for preschool children. Parents’ reluctance to go to school or to sleep without being near the parents,
reassurance is usually sufficient to help the child through this period. persistent avoidance of being alone, nightmares involving themes of
Although most school-age children abandon the imaginary fears of separation, numerous somatic symptoms, and complaints of subjective
early childhood, some replace them with fears of bodily harm or other distress. The first clinical sign might not appear until 3rd or 4th grade,
worries (Table 38.2). In adolescence, general worrying about school typically after a holiday or a period where the child has been home
performance and worrying about social competence are common and because of illness, or when the stability of the family structure has been
remit as the teen matures. threatened by illness, divorce, or other psychosocial stressors.
Genetic or temperamental factors contribute more to the development Symptoms vary depending on the child’s age: Children <8 yr often
of some anxiety disorders, whereas environmental factors are closely have associated school refusal and excessive fear that harm will come
linked to the cause of others. Specifically, behavioral inhibition appears to a parent; children 9-12 yr have excessive distress when separated
to be a heritable tendency and is linked with social phobia, generalized from a parent; and those 13-16 yr often have school refusal and physical
anxiety, and selective mutism. OCD and other disorders associated complaints. SAD may be more likely to develop in children with lower
with OCD-like behaviors, such as Tourette syndrome and other tic levels of psychosocial maturity. Parents are often unable to be assertive
disorders, tend to have high genetic risk as well (see Chapter 37.1). in returning the child to school. Mothers of children with SAD often
Environmental factors, such as parent–infant attachment and exposure have a history of an anxiety disorder. In these cases the pediatrician
to trauma, contribute more to SAD and PTSD. Parental anxiety disorder should screen for parental depression or anxiety. Often, referral for
is associated with an increased risk of anxiety disorder in offspring. parental treatment or family therapy is necessary before SAD and
Differences in the size of the amygdala and hippocampus are noted in concomitant school refusal can be successfully treated.
patients with anxiety symptoms. Comorbidity is common in SAD. In children with comorbid tic
Separation anxiety disorder is one of the most common childhood disorders and anxiety, SAD is especially associated with tic severity.
anxiety disorders, with a prevalence of 3.5–5.4%. Approximately 30% SAD is a predictor for early onset of PD. Children with SAD compared
of children presenting to an outpatient anxiety disorder clinic have to those without SAD are 3 times more likely to develop PD in
SAD as a primary diagnosis. Separation anxiety is developmentally adolescence.
normal when it begins about 10 mo of age and tapers off by 18 mo. By When a child reports recurring acute severe anxiety, antidepressant
3 yr of age, most children can accept the temporary absence of their or anxiolytic medication is often necessary. Controlled studies of tricyclic
mother or primary caregiver. antidepressants (TCAs, imipramine) and benzodiazepines (clonazepam)
SAD is more common in prepubertal children, with an average age show that these agents are not generally effective. Data support the use
of onset of 7.5 yr. Girls are more frequently affected than boys. SAD is of cognitive-behavioral therapy (CBT) and selective serotonin reuptake
characterized by unrealistic and persistent worries about separation inhibitors (SSRIs) (see Chapter 33, Table 33.4). Adverse events with
from the home or a major attachment figure. Concerns include possible SSRI treatment, including suicidal and homicidal ideation, are uncom-
mon. CBT alone is associated with less insomnia, fatigue, sedation, and
restlessness than SSRIs. Combining SSRIs with CBT may be the best
approach to achieving a positive response; long-term SSRI treatment
Table 38.2 DSM-5 Diagnostic Criteria for Specific Phobia can provide additional benefit.
Childhood-onset social phobia (social anxiety disorder) is character-
A. Marked fear or anxiety about a specific object or situation (e.g., ized by excessive anxiety in social settings (including the presence of
flying, heights, animals, receiving an injection, seeing blood). unfamiliar peers, or unfamiliar adults) or performance situations, leading
Note: In children, the fear or anxiety may be expressed by crying, to social isolation, and is associated with social scrutiny and fear of
tantrums, freezing, or clinging. doing something embarrassing (Table 38.3). Fear of social settings can
B. The phobic object or situation almost always provokes also occur in other disorders, such as GAD. Avoidance or escape from
immediate fear or anxiety.
C. The phobic object or situation is actively avoided or endured
the situation usually dissipates anxiety in social phobia (SP), unlike
with intense fear or anxiety. GAD, where worry persists.
D. The fear or anxiety is out of proportion to the actual danger Children and adolescents with SP often maintain the desire for
posed by the specific object or situation and to the sociocultural involvement with family and familiar peers. When severe, the anxiety
context. can manifest as a panic attack. SP is associated with a decreased quality
E. The fear, anxiety, or avoidance is persistent, typically lasting for of life, with increased likelihood of having failed at least 1 grade, and
6 mo or more. a 38% likelihood of not graduating from high school. Its onset is typically
F. The fear, anxiety, or avoidance causes clinically significant during or before adolescence and is more common in girls. A family
distress or impairment in social, occupational, or other important history of SP or extreme shyness is common. Approximately 70–80%
areas of functioning.
G. The disturbance is not better explained by the symptoms of
of patients with SP have at least 1 comorbid psychiatric disorder. Most
another mental disorder, including fear, anxiety and avoidance shy patients do not have SP.
or situations associated with panic-like symptoms or other Social effectiveness therapy for children (SET-C), alone or with
incapacitating symptoms (as in agoraphobia); objects or SSRIs, is considered the treatment of choice for SP (see Table 33.4).
situations related to obsessions (as in obsessive-compulsive SSRI and SET-C are superior to placebo in reducing social distress and
disorder); remainders of traumatic events (as in posttraumatic behavioral avoidance and increasing general functioning. SET-C may
stress disorder); separation from home or attachment figures (as be better than SSRI in reducing these symptoms. SET-C, but not SSRI,
in separation anxiety disorder); or social situations (as in social may be superior to placebo in improving social skills, decreasing anxiety
anxiety disorder). in specific social interactions, and enhancing social competence. SSRIs
Specify if:
Code based on the phobic stimulus: have a maximum effect by 8 wk; SET-C provides continued improvement
Animal (e.g., spiders, insects, dogs). through 12 wk. A combination of SSRI and CBT is superior to either
Natural environment (e.g., heights, storms, water). treatment alone in reducing severity of anxiety in children with SP and
Blood-injection-injury (e.g., needles, invasive medical other anxiety disorders. β-Adrenergic blocking agents are used to treat
procedures). SP, particularly the subtype with performance anxiety and stage fright.
Situational (e.g., airplanes, elevators, enclosed places). β-Blockers are not approved by the U.S. Food and Drug Administration
Other (e.g., situations that may lead to choking or vomiting; in (FDA) for SP.
children, e.g., loud sounds or costumed characters). School refusal, which occurs in approximately 1–2% of children, is
From the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, associated with anxiety in 40–50% of cases, depression in 50–60% of
(Copyright 2013). American Psychiatric Association, pp 197–198. cases, and oppositional behavior in 50% of cases. Younger anxious
Downloaded for Anonymous User (n/a) at GEORGE WASHINGTON UNIVERSITY from ClinicalKey.com by Elsevier on July
22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
212 Part III ◆ Behavioral and Psychiatric Disorders
Table 38.3 DSM-5 Diagnostic Criteria for Social Anxiety Table 38.4 DSM-5 Diagnostic Criteria for Panic Disorder
Disorder (Social Phobia)
A. Recurrent unexpected panic attacks. A panic attack is an abrupt
A. Marked fear or anxiety about 1 or more social situations in which surge of intense fear or intense discomfort that reaches a peak
the individual is exposed to possible scrutiny by others. within minutes, and during which time 4 (or more) of the
Examples include social interactions (e.g., having a conversation, following symptoms occur:
meeting unfamiliar people), being observed (e.g., eating or Note: The abrupt surge can occur from a calm state or an anxious
drinking), and performing in front of others (e.g., giving a state.
speech). 1. Palpitations, pounding heart, or accelerated heart rate.
B. The individual fears that he or she will act in a way or show 2. Sweating.
anxiety symptoms that will be negatively evaluated (i.e., will be 3. Trembling or shaking.
humiliating or embarrassing; will lead to rejection or offend 4. Sensations of shortness of breath or smothering.
others). 5. Feelings of choking.
C. The social situations almost always provoke fear or anxiety. 6. Chest pain or discomfort.
Note: In children, the fear or anxiety may be expressed by crying, 7. Nausea or abdominal distress.
tantrums, freezing, clinging, shrinking, or failing to speak in social 8. Feeling dizzy, unsteady, light-headed, or faint.
situations. 9. Chills or heart sensations.
D. The social situations are avoided or endured with intense fear or 10. Paresthesias (numbness or tingling sensations).
anxiety. 11. Derealizations (feeling or unreality) or depersonalization
E. The fear or anxiety is out of proportion to the actual threat (being detached from one-self).
posed by the social situation and to the sociocultural context. 12. Fear of losing control or “going crazy.”
F. The fear, anxiety, or avoidance is persistent, typically lasting for 13. Fear of dying.
6 mo or more. Note: Culture-specific symptoms (e.g., tinnitus, neck soreness,
G. The fear, anxiety, or avoidance causes clinically significant headache, uncontrollable screaming or crying) may be seen.
distress or impairment in social, occupational, or other important Such symptoms should not count as 1 of the 4 required
areas of functioning. symptoms.
H. The fear, anxiety, or avoidance is not attributable to the B. At least 1 of the attacks has been followed by 1 mo (or more) of
physiologic effects of a substance (e.g., a drug of abuse, a 1 or both of the following:
medication) or another medical condition. 1. Persistent concern or worry about additional panic attacks or
I. The fear, anxiety, or avoidance is not better explained by the their consequences (e.g., losing control, having a heart attack,
symptoms of another mental disorder, such as panic disorder, “going crazy”).
body dysmorphic disorder, or autism spectrum disorder. 2. A significant maladaptive change in behavior related to the
J. If another medical condition (e.g., Parkinson disease, obesity, attacks (e.g., behaviors designed to avoid having panic
disfigurement from burns or injury) is present, the anxiety or attacks, such as avoidance of exercise or unfamiliar situations).
avoidance is clearly unrelated or is excessive. C. The disturbance is not attributable to the physiologic effects of
Specify if: a substance (e.g., a drug of abuse, a medication) or another
Performance only: If the fear is restricted to speaking or performing medical condition (e.g., hyperthyroidism, cardiopulmonary
in public. disorders).
D. The disturbance is not better explained by another mental
From the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, disorder (e.g., the panic attacks do not occur only in response to
(Copyright 2013). American Psychiatric Association, pp 202–203. feared social situations, as in social anxiety disorder; in response
to circumscribed phobic objects or situations, as in specific
phobia; in response to obsessions, as in obsessive-compulsive
disorder; or in response to reminders of traumatic events, as in
children who refuse to attend school are more likely to have SAD, posttraumatic stress disorder; or in response to separation from
whereas older anxious children usually refuse to attend school because attachment figures, as in separation anxiety disorder).
of SP. Somatic symptoms, especially abdominal pain and headaches,
From the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition,
are common. There may be increasing tension in the parent–child (Copyright 2013). American Psychiatric Association, pp 208–209.
relationship or other indicators of family disruption (domestic violence,
divorce, or other major stressors) contributing to school refusal.
Management of school refusal typically requires parent management
training and family therapy. Working with school personnel is always
indicated; anxious children often require special attention from teachers, Panic disorder is a syndrome of recurrent, discrete episodes of marked
counselors, or school nurses. Parents who are coached to calmly send fear or discomfort in which patients experience abrupt onset of physical
the child to school and to reward the child for each completed day of and psychological symptoms called panic attacks (Table 38.4). Physical
school are usually successful. In cases of ongoing school refusal, referral symptoms can include palpitations, sweating, shaking, shortness of
to a child and adolescent psychiatrist and psychologist is indicated. SSRI breath, dizziness, chest pain, and nausea. Children can present with
treatment may be helpful. Young children with affective symptoms have acute respiratory distress but without fever, wheezing, or stridor, ruling
a good prognosis, whereas adolescents with more insidious onset or out organic causes of the distress. The associated psychological symptoms
with significant somatic complaints have a more guarded prognosis. include fear of death, impending doom, loss of control, persistent
Selective mutism is conceptualized as a disorder that overlaps with concerns about having future attacks, and avoidance of settings where
SP. Children with selective mutism talk almost exclusively at home, attacks have occurred (agoraphobia, Table 38.5).
although they are reticent in other settings, such as school, daycare, or PD is uncommon before adolescence, with the peak age of onset at
even relatives’ homes. The mutism must be present for ≥1 mo. Often, 15-19 yr, occurring more often in girls. The postadolescence prevalence
one or more stressors, such as a new classroom or conflicts with parents of PD is 1–2%. Early-onset PD and adult-onset PD do not differ in
or siblings, drive an already shy child to become reluctant to speak. It symptom severity or social functioning. Early-onset PD is associated
may be helpful to obtain history of normal language use in at least one with greater comorbidity, which can result from greater familial loading
situation to rule out any communication disorder (fluency disorder), for anxiety disorders in the early-onset subtype. Children of parents
neurologic disorder, or pervasive developmental disorder (autism, with PD are much more likely to develop PD. A predisposition to
schizophrenia) as a cause of mutism. Fluoxetine in combination with react to autonomic arousal with anxiety may be a specific risk factor
behavioral therapy is effective for children whose school performance leading to PD. Twin studies suggest that 30–40% of the variance is
is severely limited by their symptoms (see Chapter 52). Other SSRIs attributed to genetics. The increasing rates of panic attack are also directly
may also be effective. related to earlier sexual maturity. Cued panic attacks can be present in
Downloaded for Anonymous User (n/a) at GEORGE WASHINGTON UNIVERSITY from ClinicalKey.com by Elsevier on July
22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
Chapter 38 ◆ Anxiety Disorders 213
Table 38.5 DSM-5 Diagnostic Criteria for Agoraphobia Table 38.6 DSM-5 Diagnostic Criteria for Generalized
Anxiety Disorder
A. Marked fear or anxiety about 2 (or more) if the following 5
situations: A. Excessive anxiety and worry (apprehensive expectation),
1. Using public transportation (e.g., automobiles, buses, trains, occurring more days than not for at least 6 mo, about a number
ships, planes). of events or activities (such as work or school performance).
2. Being in open spaces (e.g., parking lots, marketplaces, B. The individual finds it difficult to control the worry.
bridges). C. The anxiety and worry are associated with 3 (or more) of the
3. Being in enclosed places (e.g., shops, theaters, cinemas). following 6 symptoms (with at least some symptoms having
4. Standing in line or being in a crowd. been present for more days than not for the past 6 mo):
5. Being outside of the home alone. Note: Only 1 item is required in children.
B. The individual fears or avoids these situations because of 1. Restlessness or feeling keyed up or on edge.
thoughts that escape might be difficult or help might not be 2. Being easily fatigued.
available in the event of a developing panic-like symptoms or 3. Difficulty concentrating or mind going blank.
other incapacitating or embarrassing symptoms (e.g., fear or 4. Irritability.
falling in the elderly, fear of incontinence). 5. Muscle tension.
C. The agoraphobic situations almost always provoke fear or 6. Sleep disturbance (difficulty falling or staying asleep, or
anxiety. restless, unsatisfying sleep).
D. The agoraphobic situations are actively avoided, require the D. The anxiety, worry, or physical symptoms cause clinically
presence of a companion, or are endured with intense fear or significant distress or impairment in social, occupational, or
anxiety. other important areas of functioning.
E. The fear or anxiety is out of proportion to the actual danger E. The disturbance is not attributable to the physiologic effects of
posed by the agoraphobic situations and to the sociocultural a substance (e.g., a drug of abuse, a medication) or other
context. medical condition (e.g., hyperthyroidism).
F. The fear, anxiety, or avoidance is persistent, typically lasting for F. The disturbance is not better explained by another mental
6 mo or more. disorder (e.g., anxiety or worry about having panic attacks in
G. The fear, anxiety, or avoidance causes clinically significant panic disorder, negative evaluation in social anxiety disorder
distress or impairment in social, occupational, or other important [social phobia], contamination or other obsessions in obsessive-
area of functioning. compulsive disorder, separation from attachment figures in
H. If another medical condition (e.g., inflammatory bowel disease, separation anxiety disorder, remainders of traumatic events in
Parkinson disease) is present, the fear, anxiety, or avoidance is posttraumatic stress disorder, gaining weight in anorexia
clearly excessive. nervosa, physical complaints in somatic symptom disorder,
I. The fear, anxiety, or avoidance is not better explained by the perceived appearance flaws in body dysmorphic disorder,
symptoms or another mental disorder—for example, the having a serious illness in illness anxiety disorder, or the content
symptoms are not confined to specific phobia, situational type; of delusional beliefs in schizophrenia or delusional disorder).
do not involve only social situations (as in social anxiety
disorder); and are not related exclusively to obsessions (as in From the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition,
obsessive-compulsive disorder), reminders or traumatic events (Copyright 2013). American Psychiatric Association, p 222.
(as in posttraumatic stress disorder), or fear of separation (as in
separation anxiety disorder).
Note: Agoraphobia is diagnosed irrespective of the presence of
panic disorder. If an individual’s presentation meets criteria for
simple phobia and PD. Onset may be gradual or sudden, although GAD
panic disorder and agoraphobia, both diagnoses should be seldom manifests until puberty. Boys and girls are equally affected before
assigned. puberty, when GAD becomes more prevalent in girls. The prevalence
of GAD ranges from 2.5–6% of children. Hypermetabolism in frontal
From the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, precortical area and increased blood flow in the right dorsolateral
(Copyright 2013). American Psychiatric Association, pp 217–218.
prefrontal cortex may be present.
Children with GAD are good candidates for CBT, an SSRI, or their
combination (see Table 33.4). Buspirone may be used as an adjunct to
other anxiety disorders and differ from the uncued “out-of-the-blue” SSRI therapy. The combination of CBT and SSRI often results in a
attacks in PD. superior response in pediatric patients with anxiety disorders, including
No randomized controlled trials (RCTs) have evaluated the effective- GAD. The recovery rate is approximately 80%.
ness of antidepressant medication in youth with PD. Open-label studies It is important to distinguish children with GAD from those who
with SSRIs appear to show effectiveness in the treatment of adolescents present with specific repetitive thoughts that invade consciousness
(see Table 33.4). CBT may also be helpful. The recovery rate is approxi- (obsessions) or repetitive rituals or movements that are driven by anxiety
mately 70%. (compulsions). The most common obsessions are concerned with bodily
Generalized anxiety disorder occurs in children who often experience wastes and secretions, the fear that something calamitous will happen,
unrealistic worries about different events or activities for at least 6 mo or the need for sameness. The most common compulsions are handwash-
with at least 1 somatic complaint (Table 38.6). The diffuse nature of the ing, continual checking of locks, and touching. At times of stress (bedtime,
anxiety symptoms differentiates it from other anxiety disorders. Worries preparing for school), some children touch certain objects, say certain
in children with GAD usually center around concerns about competence words, or wash their hands repeatedly.
and performance in school and athletics. GAD often manifests with Obsessive-compulsive disorder is diagnosed when the thoughts or
somatic symptoms, including restlessness, fatigue, problems concentrat- rituals cause distress, consume time, or interfere with occupational or
ing, irritability, muscle tension, and sleep disturbance. Given the somatic social functioning (Table 38.7). In the DSM-5, OCD and related disorders,
symptoms characteristic of GAD, the differential diagnosis must consider such as trichotillomania, excoriation, body dysmorphic disorder, and
other medical causes. Excessive use of caffeine or other stimulants in hoarding, are listed separately and are no longer included under anxiety
adolescence is common and should be determined with a careful history. disorders.
When the history or physical examination is suggestive, the pediatrician OCD is a chronically disabling illness characterized by repetitive,
should rule out hyperthyroidism, hypoglycemia, lupus, pheochromo- ritualistic behaviors over which the patient has little or no control. OCD
cytoma, and other disorders (see Table 38.1; Fig. 38.2). has a lifetime prevalence of 1–3% worldwide, and as many as 80% of
Children with GAD are extremely self-conscious and perfectionistic all cases have their onset in childhood and adolescence. Common
and struggle with more intense distress than is evident to parents or obsessions include contamination (35%) and thoughts of harming loved
others around them. They often have other anxiety disorders, such as ones or oneself (30%). Washing and cleaning compulsions are common
Downloaded for Anonymous User (n/a) at GEORGE WASHINGTON UNIVERSITY from ClinicalKey.com by Elsevier on July
22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
214 Part III ◆ Behavioral and Psychiatric Disorders
No Yes
Yes No
Fig. 38.2 Evaluation of worry, fear, and panic. PANDAS, Pediatric autoimmune neuropsychiatric disorders associated with Streptococcus pyogenes.
(From Kliegman RM, Lye PS, Bordini B, et al, editors: Nelson pediatric symptom-based diagnosis, Philadelphia, 2018, Elsevier, p 429).
in children (75%), as are checking (40%) and straightening (35%). Many with SSRI, when symptoms are moderate to severe (YBOCS >21). In
children are observed to have visuospatial irregularities, memory OCD patients with comorbid tics, SSRIs are no more effective than
problems, and attention deficits, causing academic problems not explained placebo, and the combination of CBT and SSRI is superior to CBT;
by OCD symptoms alone. CBT alone is superior to placebo. Pediatric OCD patients with comorbid
The Children’s Yale-Brown Obsessive-Compulsive Scale (C-YBOCS) tics should begin treatment with CBT alone or combined CBT and
and the Anxiety Disorders Interview Schedule for Children (ADIS-C) SSRI. Pediatric patients with OCD who have a family history of OCD
are reliable and valid methods for identifying children with OCD. The may be significantly less responsive to CBT alone than patients without
C-YBOCS is helpful in following the progression of symptoms with a family history.
treatment. The Leyton Obsessional Inventory (LOI) is a self-report measure There are 4 FDA-approved medications for pediatric OCD: fluoxetine,
of OCD symptoms that is quite sensitive. Patients with OCD have sertraline, fluvoxamine, and clomipramine. Clomipramine, a heterocyclic
consistently identified abnormalities in the frontostriatal-thalamic antidepressant and nonselective serotonin and norepinephrine reuptake
circuitry associated with severity of illness and treatment response. inhibitor, is only indicated when a patient has failed 2 or more SSRI
Comorbidity is common in OCD, with 30% of patients having comorbid trials. There may be a role for glutamate-modulating medications in
tic disorders, 26% comorbid major depression, and 24% comorbid the treatment of OCD. The glutamate inhibitor riluzole (Rilutek) is FDA
developmental disorders. approved for amyotrophic lateral sclerosis (see Chapter 630.3) and has
Consensus guidelines recommend that children and adolescents with a good safety record. The most common adverse event with riluzole is
OCD begin treatment with either CBT alone or CBT in combination transient increase in liver transaminases. Riluzole in children with
Downloaded for Anonymous User (n/a) at GEORGE WASHINGTON UNIVERSITY from ClinicalKey.com by Elsevier on July
22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
Chapter 38 ◆ Anxiety Disorders 215
treatment-resistant OCD may be beneficial and is well tolerated. Other by calmly noting that phobias are not unusual and rarely cause impair-
glutamate-modulating agents, such as memantine, N-acetylcysteine, ment. The prevalence of specific phobias in childhood is 0.5–2%.
and D-cycloserine, have been used with some success in patients with Systematic desensitization is a form of behavior therapy that gradually
OCD. Referral of patients with OCD to a mental health professional is exposes the patient to the fear-inducing situation or object, while
always indicated. simultaneously teaching relaxation techniques for anxiety management.
In 10% of children with OCD, symptoms are triggered or exacerbated Successful repeated exposure leads to extinguishing anxiety for that
by group A β-hemolytic streptococcal infection (see Chapter 210). Group stimulus. When phobias are particularly severe, SSRIs can be used with
A β-hemolytic streptococci trigger antineuronal antibodies that cross- behavioral intervention. Low-dose SSRI treatment may be especially
react with basal ganglia neural tissue in genetically susceptible hosts, effective for some children with severe, refractory choking phobia.
leading to swelling of this region and resultant obsessions and compul- Posttraumatic stress disorder is typically precipitated by an extreme
sions. This subtype of OCD, called pediatric autoimmune neuropsy- stressor (see Chapter 14). PTSD is an anxiety disorder resulting from
chiatric disorder associated with streptococcal infection (PANDAS), the long- and short-term effects of trauma that cause behavioral and
is characterized by sudden and dramatic onset or exacerbation of OCD physiologic sequelae in toddlers, children, and adolescents (Table 38.8).
or tic symptoms, associated neurologic findings, and a recent streptococcal Another diagnostic category, acute stress disorder, reflects that traumatic
infection. Increased antibody titers of antistreptolysin O and antide- events often cause acute symptoms that may or may not resolve. Previous
oxyribonuclease B correlates with increased basal ganglia volumes. trauma exposure, a history of other psychopathology, and symptoms
Plasmapheresis is effective in reducing OCD symptoms in some patients of PTSD in parents predict childhood-onset PTSD. Many adolescent
with PANDAS and also decreasing enlarged basal ganglia volume. OCD and adult psychopathologic conditions, such as conduct disorder,
has also followed episodes of acute disseminated encephalomyelitis (see depression, and some personality disorders, might relate to previous
Chapter 618.4) The pediatrician should be aware of the infectious cause trauma. PTSD is also linked to mood disorders and disruptive behavior.
of some cases of tic disorders, and OCD and follow management Separation anxiety is common in children with PTSD. The lifetime
guidelines (see Chapter 37). prevalence of PTSD by age 18 yr is approximately 6%. Up to 40% show
Children with phobias avoid specific objects or situations that reliably symptoms, but do not fulfill the diagnostic criteria.
trigger physiologic arousal (e.g., dogs, spiders) (see Table 38.2). The Events that pose actual or threatened physical injury, harm, or death
fear is excessive and unreasonable and can be cued by the presence or to the child, child’s caregiver, or others close to the child, and that
anticipation of the feared trigger, with anxiety symptoms occurring produce considerable stress, fear, or helplessness, are required to make
immediately. Neither obsessions nor compulsions are associated with the diagnosis of PTSD. Three clusters of symptoms are also essential
the fear response; phobias only rarely interfere with social, educational, for diagnosis: reexperiencing, avoidance, and hyperarousal. Persistent
or interpersonal functioning. Assault by a relative and verbal aggression reexperiencing of the stressor through intrusive recollections, nightmares,
between parents can influence the onset of specific phobias. The parents and reenactment in play are typical responses in children. Persistent
of phobic children should remain calm in the face of the child’s anxiety avoidance of reminders and numbing of emotional responsiveness,
or panic. Parents who become anxious themselves may reinforce their such as isolation, amnesia, and avoidance, constitute the 2nd cluster of
children’s anxiety, and the pediatrician can usefully interrupt this cycle behaviors. Symptoms of hyperarousal, such as hypervigilance, poor
Continued
Downloaded for Anonymous User (n/a) at GEORGE WASHINGTON UNIVERSITY from ClinicalKey.com by Elsevier on July
22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
216 Part III ◆ Behavioral and Psychiatric Disorders
Downloaded for Anonymous User (n/a) at GEORGE WASHINGTON UNIVERSITY from ClinicalKey.com by Elsevier on July
22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
concentration, extreme startle responses, agitation, and sleep problems, The experiences of the siblings of children with chronic illness are
complete the symptom profile of PTSD. Occasionally, children regress often forgotten, with familial resources focused on medical-financial
in some of their developmental milestones after a traumatic event. consequences and the emotional and physical functioning of the ill
Avoidance symptoms are usually observable in younger children, whereas child. It is not uncommon for the siblings of ill children to experience
older children may better describe reexperiencing and hyperarousal depression and anxiety as well. Assessing their social support systems,
symptoms. Repetitive play involving the event, psychosomatic symptoms, communication opportunities with parents and emotional outlets are
and nightmares may also be observed. critical to maintaining healthy functioning. Maintaining a redefined
Initial interventions after a trauma should focus on reunification schedule of after-school activities and social engagements are helpful
with a parent and attending to the child’s physical needs in a safe place. in allowing siblings to continue in school.
Aggressive treatment of pain, and facilitating a return to comforting
routines, including regular sleep, is indicated. Long-term treatment SAFETY AND EFFICACY CONCERNS ABOUT SSRIS
may include individual, group, school-based, or family therapy, as well No empirical evidence suggests the superiority of one SSRI over another.
as pharmacotherapy, in selected cases. Individual treatment involves Data are limited on combining medications. SSRIs are usually well
transforming the child’s concept of himself or herself as victim to that tolerated by most children and adolescents. The FDA issued a “black
of survivor and can occur through play therapy, psychodynamic therapy, box” warning of increased agitation and suicidality among adolescents
or CBT. Group work is also helpful for identifying which children might and children taking SSRIs. This warning was based on review of studies
need more intensive assistance. Goals of family work include helping in children and adolescents with major depression and not anxiety
the child establish a sense of security, validating the child’s emotions, disorders. Close monitoring is always warranted.
and anticipating situations when the child will need more support from
the family. Bibliography is available at Expert Consult.
Clonidine or guanfacine may be helpful for sleep disturbance, persistent
arousal, and exaggerated startle response. Recent RCTs in children and
adolescents with PTSD found no significant difference between SSRI
and placebo. SSRIs may be considered in pediatric patients with PTSD
who have comorbid conditions responsive to SSRIs, including depression,
affective numbing, and anxiety (see Table 33.4). As for many other
anxiety disorders, CBT is the psychotherapeutic intervention with the
most empirical support.
Downloaded for Anonymous User (n/a) at GEORGE WASHINGTON UNIVERSITY from ClinicalKey.com by Elsevier on July
22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
Chapter 38 ◆ Anxiety Disorders 217.e1
Bibliography Hirschritt ME, Bloch MH, Mathews CA: Obsessive-compulsive disorder: advances
American Psychiatric Association: Diagnostic and statistical manual of mental disorders, in diagnosis and treatment, JAMA 317(13):1358–1367, 2017.
ed 5, Washington, DC, 2013, American Psychiatric Association. Hoge EA, Ivkovic A, Fricchione GL: Generalized anxiety disorder: diagnosis and
Baldwin D, Woods R, Lawson R, et al: Efficacy of drug treatments for generalized treatment, BMJ 345:37–42, 2012.
anxiety disorder: systematic review and meta-analysis, BMJ 342:637, 2011. Kurlam R, Johnson D, Kaplan EL: Streptococcal infection and exacerbations of child-
Beidel DC, Turner SM, Sallee FR, et al: SET-C versus fluoxetine in the treatment of hood tics and obsessive-compulsive symptoms: a prospective blinded cohort study,
childhood social phobia, J Am Acad Child Adolesc Psychiatry 46:1622–1632, 2007. Pediatrics 121:1188–1197, 2008.
Bridge JA, Iyengar S, Salary CB, et al: Clinical response and risk for reported suicidal Leichsenring F, Leweke F: Social anxiety disorder, N Engl J Med 376(23):2255–2264, 2017.
ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis March JS, Franklin ME, Leonard H, et al: Tics moderate treatment outcome with
of randomized controlled trials, JAMA 297:1683–1696, 2007. sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive
Brezo J, Barker ED, Paris J, et al: Childhood trajectories of anxiousness and disruptive- disorder, Biol Psychiatry 61:344–347, 2007.
ness as predictors of suicide attempts, Arch Pediatr Adolesc Med 162:1015–1021, 2008. Muir KE, McKenney KS, Connolly MB, et al: A case report of obsessive-compulsive
Burstein M, Ameli-Grillon L, Merikangas KR: Shyness versus social phobia in US disorder following acute disseminated encephalomyelitis, Pediatrics 132:e771–e774,
youth, Pediatrics 128:917–925, 2011. 2013.
Craske MG, Stein MB: Anxiety, Lancet 388:3028–3058, 2016. Nicholson TRJ, Ferdinando S, Krishnaiah RB, et al: Prevalence of anti-basal ganglia
Dougherty LR: Tolep MR: Preschool anxiety disorders: comprehensive assessment antibodies in adult obsessive-compulsive disorder cross-sectional study, Br J
of clinical, demographic, temperamental, familial, and life stress correlates, J Clin Psychiatry 200(5):381–386, 2012.
Child Adolesc Psychol 42:577–589, 2013. Pavone P, Parano E, Rizzo R, et al: Autoimmune neuropsychiatric disorders associated
Forman-Hoffman VL, Zolotor AJ, McKeeman JL, et al: Comparative effectiveness of with streptococcal infection: sydenham chorea, PANDAS, and PANDAS variants,
interventions for children exposed to nonrelational traumatic events, Pediatrics J Child Neurol 21:727–736, 2006.
131(3):526–539, 2013. Ramsawh HJ, Chavira DA, Stein MB: Burden of anxiety disorders in pediatric medical
Franklin ME, Sapyta J, Freeman JB, et al: Cognitive behavior therapy augmentation of settings, Arch Pediatr Adolesc Med 164:965–972, 2010.
pharmacotherapy in pediatric obsessive-compulsive disorder, JAMA 306:1224–1232, Rockhill C, Kodish I, DiBattisto C, et al: Anxiety disorders in children and adolescents,
2011. Curr Probl Pediatr Adolesc Health Care 40(4):65–100, 2010.
Freeman J, Sapyta J, Garcia A, et al: Family-based treatment of early childhood Rosenberg DR, Gershon S, editors: Pharmacotherapy of child and adolescent psychiatric
obsessive-compulsive disorder. The Pediatric Obsessive-Compulsive Disorder disorders, I, ed 3, Chichester, West Sussex, UK, 2012, John Wiley & Sons, pp 1–475.
Treatment Study for Young Children (POTS Jr): a randomized clinical trial, JAMA Roy-Byrne PP, Craske MG, Stein MB: Panic disorder, Lancet 368:1023–1032, 2006.
Psychiatry 71:689–698, 2014. Scahill L, Riddle MA, McSwiggin-Hardin M, et al: Children’s Yale-Brown obsessive
Garcia AM, Sapyta JJ, Moore PS, et al: Predictors and moderators of treatment outcome compulsive scale: reliability and validity, J Am Acad Child Adolesc Psychiatry
in the Pediatric Obsessive Compulsive Treatment Study (POTS I), J Am Acad Child 36:844–852, 1997.
Adolesc Psychiatry 49:1024–1033, 2010. Shalev A, Liberzon I, Marmar C: Post-traumatic stress disorder, N Engl J Med 376(25):
Ginsburg GS, Drake KL, Tein JY, et al: Preventing onset of anxiety disorders in offspring 2459–2468, 2017.
of anxious parents: a randomized controlled trial of a family-based intervention, Stein MB, Sareen J: Generalized anxiety disorder, N Engl J Med 373(21):2059–2068, 2015.
Am J Psychiatry 172(12):1207–1214, 2015. Thirlwall K, Cooper PJ, Karalus J, et al: Treatment of child anxiety disorders via guided
Grant JE: Obsessive-compulsive disorder, N Engl J Med 371:646–652, 2014. parent-delivered cognitive-behavioural therapy: randomized controlled trial, Br J
Grant P, Lougee L, Hirschtritt M, et al: An open-label trial of riluzole, a glutamate Psychiatry 203:436–444, 2013.
antagonist, in children with treatment-resistant obsessive-compulsive disorder, Tyrer P, Baldwin D: Generalized anxiety disorder, Lancet 368:2156–2166, 2006.
J Child Adolesc Psychopharmacol 17:761–767, 2007. Veale D, Roberts A: Obsessive-compulsive disorder, BMJ 348:31–34, 2014.
Herr NR, Williams JW Jr, Benjamin S, et al: Does this patient have generalized Weersing VR, Brent DA, Rozenman MS, et al: Brief behavioral therapy for pediatric
anxiety or panic disorder? The rational clinical examination systematic review, anxiety and depression in primary care: a randomized clinical trial, JAMA Psychiatry
JAMA 312:78–84, 2014. 74(6):571–578, 2017.
Downloaded for Anonymous User (n/a) at GEORGE WASHINGTON UNIVERSITY from ClinicalKey.com by Elsevier on July
22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.